Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is undoubtedly the most challenging pandemic in the current century and remains a global health emergency. As the number of COVID-19 cases in the world is on the rise and variants continue to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Cong, Rcheulishvili, Nino, Shen, Zhigao, Papukashvili, Dimitri, Xie, Fengfei, Wang, Ziqian, Wang, Xingyun, He, Yunjiao, Wang, Peng George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143166/
https://www.ncbi.nlm.nih.gov/pubmed/35631687
http://dx.doi.org/10.3390/pharmaceutics14051101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143166/
https://www.ncbi.nlm.nih.gov/pubmed/35631687
http://dx.doi.org/10.3390/pharmaceutics14051101

Ejemplares similares